Icelandic biotech R&D company Akthelia Pharmaceuticals has appointed Brynjólfur Þór Gylfason as Financial Controller. Gylfason brings more than twenty years of financial leadership experience across the biotechnology and healthcare sectors, investment management, and advisory services. He joins Akthelia from GS Holdings Group. He has also held roles at Danforth Advisors, WuXi NextCODE, Virðing hf., and Deloitte. Gylfason holds a Cand. Oecon. degree in Auditing from the Univer

Icelandic biotech R&D company Akthelia Pharmaceuticals has appointed Stefán Jónsson, PhD, as Head of Chemistry, Manufacturing, and Control (CMC) and Intellectual Property. In this role, Dr. Jónsson will lead strategy and execution across development, analytical, and manufacturing processes, pharmaceutical substances and formulations, as well as the company’s intellectual property strategy. Dr. Jónsson brings two decades of experience in analytical methodologies, proteomics, m

Akthelia's CEO, Egill Masson at the International BIO Convention 2025

Tanya Zharov, attorney has joined the Board of Directors of Akthelia as an independent director. Tanya brings over 25 years of experience in biotechnology, finance, and corporate governance, with an extensive background across the pharmaceutical and life-science industries. She is current General Counsel and Deputy CEO of Icelandic biosimilar company Alvotech. prior to that she was Deputy CEO at deCODE Genetics. From 2008 to 2015, she was a Founding Partner and Deputy CEO of

Technical University Munich’s Prof. Dr. Markus Gerhard Joins Akthelia's Scientific Advisory Board.